Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.3%

1 terminated out of 23 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

13%

3 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed with results

Key Signals

2 with results93% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (7)
Early P 1 (1)
P 2 (2)
P 3 (3)

Trial Status

Completed13
Unknown4
Recruiting4
Withdrawn1
Terminated1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT02285296Not ApplicableCompletedPrimary

The Needs and Burden of Family Caregivers of Older Adults With Cancer

NCT07519811Not ApplicableRecruiting

LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL)

NCT03030248Phase 2Completed

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

NCT06523270RecruitingPrimary

Advanced Imaging Holistic Omics Biobank

NCT06782412Phase 2Recruiting

Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types

NCT06631560Not ApplicableCompleted

Hepatitis E Virus Infection in Oncological Patients

NCT05769868Phase 3Recruiting

Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments

NCT05478733CompletedPrimary

Study of Factors Associated With Significant MYoCArdian Uptake on 68Ga-DOTATOC PET Scans for Oncology

NCT06229535UnknownPrimary

The Right to be Forgotten in the AYA Population: Patients' Experience and Perspectives (Diritto All'Oblio)

NCT03978312Terminated

Nutrition Health Literacy of Cancer Patients and Their Support Networks.

NCT05132998Not ApplicableCompletedPrimary

Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors

NCT04842214UnknownPrimary

Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up

NCT04918888Completed

COVID-19 Vaccination in Oncologic Patients

NCT04420039Completed

Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction

NCT03416465CompletedPrimary

Place of General Medical During Oncology Care Management

NCT04271670Not ApplicableCompletedPrimary

Effect of Warm Water Footbaths With Added Ginger or Mustard Powder on Psychosocial Parameters in Patients With an Oncological Disease

NCT03041571Withdrawn

Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students

NCT04142463Not ApplicableUnknownPrimary

Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2

NCT03426553Phase 3CompletedPrimary

Clinical Use of Pathogen Reduced Red Blood Cell Suspension

NCT02484053Early Phase 1Completed

Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders

Scroll to load more

Research Network

Activity Timeline